Sectoral Asset Management’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,081	Closed	-$248K	–	101
2024 Q1	$248K	Sell	12,081 -800	-6%	-$15K	0.1%	86
2023 Q4	$276K	Sell	12,881 -242,060	-95%	-$4.79M	0.12%	95
2023 Q3	$5.26M	Buy	254,941 +9,650	+4%	+$245K	1.02%	38
2023 Q2	$7.24M	Buy	245,291 +441	+0.2%	+$12.4K	1.21%	32
2023 Q1	$5.64M	Buy	244,850 +1,000	+0.4%	+$27.5K	1.08%	36
2022 Q4	$6.78M	Buy	243,850 +500	+0.2%	+$14.9K	1.31%	23
2022 Q3	$7.47M	Buy	243,350 +41,250	+20%	+$1.34M	1.47%	22
2022 Q2	$5.95M	Sell	202,100 -5,000	-2%	-$131K	1.2%	32
2022 Q1	$6.66M	Buy	207,100 +17,500	+9%	+$602K	1.18%	33
2021 Q4	$8.46M	Buy	189,600 +62,100	+49%	+$2.94M	1.27%	32
2021 Q3	$6.43M	Buy	127,500 +62,500	+96%	+$3.52M	0.53%	77
2021 Q2	$5.1M	Buy	65,000 +61,000	+1,525%	+$3.77M	0.41%	86
2021 Q1	$228K	Buy	+4,000	New	+$268K	0.02%	112
2020 Q3	–	Sell	-9,600	Closed	-$232K	–	114
2020 Q2	$232K	Buy	+9,600	New	+$226K	0.02%	175